Manufacturer of Controlled Substances; Notice of Registration; Wildlife Laboratories, Inc., 49546-49547 [2013-19612]
Download as PDF
<![CDATA[
49546
Federal Register / Vol. 78, No. 157 / Wednesday, August 14, 2013 / Notices
conventions, or protocols in effect on
May 1, 1971.
DEA has investigated Arizona
Department of Corrections, ASPCFlorence to ensure that its registration is
consistent with the public interest. The
investigation has included inspection
and testing of the Arizona Department
of Corrections, ASPC-Florence facility’s
physical security systems, verification
of its compliance with state and local
laws, and a review of its background
and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR § 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substance listed.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
tkelley on DSK3SPTVN1PROD with NOTICES
Importer of Controlled Substances,
Notice of Registration, Wildlife
Laboratories Inc.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug
By Notice dated May 14, 2013, and
published in the Federal Register on
May 22, 2013, 78 FR 30329, Wildlife
Laboratories Inc., 1401 Duff Drive, Suite
400, Fort Collins, Colorado 80524, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Etorphine (except HCI) (9056), a basic
class of controlled substance listed in
schedule I.
The company plans to import the
listed controlled substance for sale to its
customer.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Wildlife Laboratories Inc. to import the
basic class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Wildlife Laboratories
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Jkt 229001
[FR Doc. 2013–19621 Filed 8–13–13; 8:45 am]
This is notice that on June 10, 2013,
Siegfried USA, LLC., 33 Industrial Park
Road, Pennsville, New Jersey 08070,
made application by letter to the Drug
Enforcement Administration (DEA) for
registration as an importer of the
following basic classes of controlled
substances:
[FR Doc. 2013–19637 Filed 8–13–13; 8:45 am]
16:16 Aug 13, 2013
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Importer of Controlled Substances;
Notice of Application; Siegfried USA,
LLC
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
VerDate Mar<15>2010
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR § 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substance listed.
Schedule
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
II
II
The company plans to import the
listed controlled substances to bulk
manufacture API’S for distribution to its
customer.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
As noted in a previous notice
published in the Federal Register on
September 23, 1975, 40 FR 43745, all
applicants for registration to import a
basic classes of any controlled
substances in schedule I or II are, and
will continue to be, required to
demonstrate to the Deputy Assistant
Administrator, Office of Diversion
Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: August 2, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–19745 Filed 8–13–13; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
IRIX Manufacturing, Inc.
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on January 18, 2013,
IRIX Manufacturing, Inc., 309 Delaware
Street, Greenville, South Carolina
29605, made application to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Noroxymorphone (9668), a basic class of
controlled substance listed in schedule
II.
The company plans to manufacture
the listed controlled substance as API
for clinical trials.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substance,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than October 15, 2013.
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–19616 Filed 8–13–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Wildlife Laboratories, Inc.
By Notice dated April 16, 2013, and
published in the Federal Register on
April 23, 2013, 78 FR 23958, Wildlife
Laboratories, Inc., 1230 W. Ash Street,
Suite D, Windsor, Colorado 80550,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of Carfentanil (9743), a
basic class of controlled substance listed
in schedule II.
The company plans to manufacture
the above listed controlled substance for
sale to veterinary pharmacies, zoos, and
for other animal and wildlife
applications.
E:\FR\FM\14AUN1.SGM
14AUN1
49547
Federal Register / Vol. 78, No. 157 / Wednesday, August 14, 2013 / Notices
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Wildlife Laboratories, Inc., to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Wildlife Laboratories, Inc.,
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic class of
controlled substance listed.
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
factors in 21 U.S.C. 823(a) and
determined that the registration of
Penick Corporation to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time.
DEA has investigated Penick
Corporation to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–19614 Filed 8–13–13; 8:45 am]
BILLING CODE 4410–09–P
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
BILLING CODE 4410–09–P
[FR Doc. 2013–19612 Filed 8–13–13; 8:45 am]
[FR Doc. 2013–19608 Filed 8–13–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Penick Corporation
Manufacturer of Controlled
Substances, Notice of Registration,
Rhodes Technologies
By Notice dated April 10, 2013, and
published in the Federal Register on
April 19, 2013, 78 FR 23595, Penick
Corporation, 33 Industrial Park Road,
Pennsville, New Jersey 08070, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
By Notice dated April 10, 2013, and
published in the Federal Register on
April 19, 2013, 78 FR 23596, Rhodes
Technologies, 498 Washington Street,
Coventry, Rhode Island 02816, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances:
tkelley on DSK3SPTVN1PROD with NOTICES
Drug
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances as bulk
controlled substance intermediates for
distribution to its customers.
No comments or objections have been
received. DEA has considered the
16:16 Aug 13, 2013
Drug
Schedule
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
VerDate Mar<15>2010
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Rhodes Technologies to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Rhodes Technologies to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Jkt 229001
DEPARTMENT OF JUSTICE
I
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for conversion and sale to dosage form
manufacturers.
Frm 00104
Fmt 4703
Manufacturer of Controlled
Substances; Notice of Registration;
American Radiolabeled Chemicals, Inc.
By Notice dated April 10, 2013, and
published in the Federal Register on
April 19, 2013, 78 FR 23596, American
Radiolabeled Chemicals, Inc., 101 Arc
Drive, St. Louis, Missouri 63146, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Schedule
Tetrahydrocannabinols (7370) .....
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Fentanyl (9801) ............................
PO 00000
Drug Enforcement Administration
Sfmt 4703
Drug
Gamma
Hydroxybutyric
Acid
(2010).
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
Dimethyltryptamine (7435) ...........
1-[1-(2Thienyl)cyclohexyl]piperidine
(7470).
Dihydromorphine (9145) ...............
Heroin (9200) ...............................
Normorphine (9313) .....................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
E:\FR\FM\14AUN1.SGM
14AUN1
Schedule
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 78, Number 157 (Wednesday, August 14, 2013)]
[Notices]
[Pages 49546-49547]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-19612]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Wildlife Laboratories, Inc.
By Notice dated April 16, 2013, and published in the Federal
Register on April 23, 2013, 78 FR 23958, Wildlife Laboratories, Inc.,
1230 W. Ash Street, Suite D, Windsor, Colorado 80550, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of Carfentanil (9743), a basic class
of controlled substance listed in schedule II.
The company plans to manufacture the above listed controlled
substance for sale to veterinary pharmacies, zoos, and for other animal
and wildlife applications.
[[Page 49547]]
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a), and determined that the registration
of Wildlife Laboratories, Inc., to manufacture the listed basic class
of controlled substance is consistent with the public interest at this
time. DEA has investigated Wildlife Laboratories, Inc., to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic class of controlled substance listed.
Dated: August 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-19612 Filed 8-13-13; 8:45 am]
BILLING CODE 4410-09-P
